Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.32 |
| ▸ | CASP3 | P42574 | 1/20 | 0.31 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6513337 | 0.75 | PIK3R1 (0.45) | ALDH1A1DYRK1ACASP3CHEK1CNR2 | |
| SCHEMBL6525537 | 0.70 | CASP3 (0.37) | HPGDALDH1A1CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL6508143 | 0.65 | PIK3R1 (0.43) | ALDH1A1CHEK1CNR2 | |
| SCHEMBL6525512 | 0.60 | MAPT (0.51) | ALDH1A1CYP1A2CYP3A4CYP2C19CNR2 | |
| SCHEMBL6508464 | 0.60 | CHEK1 (0.53) | HPGDALDH1A1CHEK1KCNH2CNR2 | |
| SCHEMBL6507976 | 0.59 | CHEK1 (0.53) | ALDH1A1CHEK1KCNH2CNR2 | |
| SCHEMBL6522871 | 0.57 | CHEK1 (0.51) | ALDH1A1CHEK1KCNH2 | |
| SCHEMBL6519279 | 0.57 | SYK (0.43) | — | |
| SCHEMBL31072035 | 0.55 | HPGD (0.43) | HPGD | |
| SCHEMBL21767502 | 0.55 | HPGD (0.43) | HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005028474-A2 | PYRAZOLOQUINOLINE DERIVATIVES AS CHK-1 INHIBITORS | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2005-03-31 | — | — | WO | disclosed |